| Project |
Indication |
Target/Strategy |
Modality |
Affiliations |
Stage |
| Oncology |
|---|
| IRICoR-ONCO-02 | Pediatric Cancer | Chemogenomic | Small molecule | Université de Montréal (IRIC) | |
| IRICoR-ONCO-03 | Cancer | RAS | Small molecule | Université de Montréal (IRIC) | |
| IRICoR-ONCO-01 | Pediatric Cancer | NK activating cells | Cell therapy | Université de Montréal (Ste-Justine Hospital) | |
| Rare Diseases |
|---|
| IRICoR-RARE-01 | Lowe Syndrome | PLC Activator | Small molecule | Université de Montréal (IRIC) | |
| Other |
|---|
| IRICoR – OTH – 01 | Neurology | Nur77/RXR | Small molecule | Université de Montréal (IRIC) | |
| Drug Discovery Platform |
|---|
| IRICoR-DDPlat-01 | Platform for the identification and design of RNA interference agents | N/A | Intefering RNAs | Université de Montréal (IRIC) | |
